We practice the values of "green, health, struggle and sharing", embrace the entrepreneurial concept of "creating first-class pharmacy for human health", and are committed to providing high-quality and inexpensive chemical services for the development of new drugs. Our company's vision is to build an efficient, high-quality new drug industrialization platform, we will follow the international, professional management model, adhere to the people-oriented and domestic and foreign counterparts side by side, for the global new drug development to do our best.

At present, the company has built a research and development center of 2500 square meters in Zhongyuan Zhigu, Xingyang City, Zhengzhou City, and now has several sets of high-precision drug analysis instruments including NMR (nuclear magnetic resonance spectrometer), LC-MS-MS (ultra-high performance liquid mass spectrometer), HPLC (high performance liquid chromatography), GC (gas chromatograph) and various advanced new drug development equipment. The company focuses on the introduction and training of high-end pharmaceutical R&D personnel at home and abroad. Now the company has 36 R & D personnel, including 6 doctors, 18 masters, R & D personnel accounted for 80% of the total number of employees, backbone employees have more than 10 years of scientific research and production practice experience. Relying on solid theory, experienced new drug development personnel and advanced high-precision instruments and equipment, we can provide customers with efficient molecular design, process optimization, quality research, engineering and other new drug development services.

In the future, Zhengzhou Institute of Chiral Drugs Research Co., Ltd.e will continue to adhere to market demand-oriented, relying on its strong new drug development capabilities, adhering to the business philosophy of "providing customers with efficient new drug development services with rock-solid reputation", creating value for customers, seeking benefits for employees, and contributing to the development of pharmaceutical industry.